Mark Bagg, MD
Orthopaedic Surgery · San Antonio, TXNPI 1730167479
Payments from drug & device makers
Across 46 payments — averaging $207.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endo Pharmaceuticals Inc.$6K
- Medinc Of Texas$2K
- Arthrex$398
- Acumed LLC$356
- Johnson & Johnson$259
- Skeletal Dynamics Inc$121
- plus $915 from 12 others
What the payments were for
- Consulting fees$4,27045%
- Travel & lodging$2,31324%
- Food & beverage$2,02721%
- Education$91310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endo Pharmaceuticals Inc. | 10 | $5,601 |
| Medinc Of Texas | 3 | $1,875 |
| Arthrex | 10 | $398 |
| Acumed LLC | 3 | $356 |
| Johnson & Johnson | 3 | $259 |
| Skeletal Dynamics Inc | 1 | $121 |
| Checkpoint Surgical, Inc | 1 | $120 |
| Arthrosurface Incorporated | 1 | $119 |
| Pacira Therapeutics, Inc. | 1 | $103 |
| Exsomed Corporation | 1 | $95 |
| Trice Medical, Inc. | 1 | $92 |
| Smith+Nephew | 1 | $88 |
| Mission Medical Distribution, LLC | 2 | $78 |
| Axogen | 3 | $65 |
| Vertex | 2 | $59 |
| Ossur Americas, Inc. | 1 | $42 |
| Endo USA, Inc. | 1 | $30 |
| Organogenesis Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XIAFLEX$5,426
- ACUMED$231
- NA$216
- INnate Implant$125
- InFrame Implant$125
- Geminus$121
- Align$121
- IJS$121
- Implate$121
- Checkpoint Stimulators$120
- WristMotion Wrist Hemiarthroplasty System$119
- Zilretta$103
How this compares
$9,524 in reported general payments places this provider in the 65th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acetaminophen-CodeineAcetaminophen With Codeine | 78 | $357 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $227 |
| Methylprednisolone | 29 | $192 |
| Tramadol Hcl | 24 | $54 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $40 |
| Meloxicam | 17 | $36 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in San Antonio
- Stephen BurkhartSan Antonio$185.3M
- Michael WirthSan Antonio$4.5M
- Charles BroomeSan Antonio$3.8M
- Christopher ChaputSan Antonio$1.1M
- Ravi KariaSan Antonio$1.1M
- Charles RockwoodSan Antonio$975K
- Frank ButtacavoliSan Antonio$932K
- Robert HartzlerSan Antonio$702K
- Bernard MorreySan Antonio$639K
- Animesh AgarwalSan Antonio$440K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.